4D Presents at IHMC 2018

June 27, 2018   |   June 2018 Bond Updates
LEEDS, England, June 27, 2018 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company's Chief Scientific Officer, Dr. Alex Stevenson, has spoken at the International Human Microbiome...

View more at: https://www.prnewswire.com/news-releases/4d-presents-at-ihmc-2018-686652161.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/